UCLA researchers in the Department of Electrical and Computer Engineering have developed a novel wearable biosensor capable of measuring biomarkers in real time through biofluids like sweat.
There is a current revolution in wearable technology to track health status in real time. In the advent of Apple watches and Fitbit, health tracking has become a hot trend that many consumers are adopting. Currently, commercialized non-invasive sensors are only capable of tracking physical activity and vital signs. However, recent advances in electrochemical sensor development has opened the opportunity to measure biofluids that are rich in biomarkers for health status. Examples of biosensors that utilize biofluids have been able to track calorimetric and electrochemical analytes but are limited in storage capacity. To realize a fully autonomous lab-on-the-body platforms with diverse operations, fundamentally, in-situ biofluid actuation and compartmentalization methodologies must be employed in conjunction with the demonstrated sensing capabilities.
In the growing field of wearable biosensors, there is a need for real time sensing of biomarkers in biofluid. However, this calls for the innovation of microfluidic technology to: utilize periodic and continuous mixing systems to segregate previous analytes, in-situ samples processing and purification for real time analysis, and the use of advanced assays to utilize micro volumes for analysis. As of yet, there exists no technology that integrates all of these features in a wearable biosensor.
Dr. Emaminejad at UCLA has developed a microfluidic wearable biosensor that utilizes a suite of programmable electro-fluidic interfaces, capable of capitalizing on the pitfalls of current technology. Briefly, the device is capable of pumping, mixing and valving for wearable sample analysis. The device has been shown to measure the flux in glucose in iontophoretically-stimulated sweat after glucose intake in fasting subjects. Such results highlight the promising potential that the device has to perform complex sample processing and analysis operations, showing promise for a fully autonomous lab-on-the-body platform for a broad range of healthcare applications.
The device has been demonstrated to measure blood glucose concentrations in sweat.
Country | Type | Number | Dated | Case |
United States Of America | Published Application | 20210022651 | 01/28/2021 | 2018-678 |
Microfluidics, Biosensor, Biofluid, Wearable Technology, Wireless Communication, Bluetooth, Sweat, Biomarkers, Calorimeter, Nanomaterials, real-time monitoring, calcium monitoring, pH monitoring, glucose monitoring